Latest News About - cardiovascular devices

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Tuesday, November 13, 2018

8:53:00 PM CET

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

David M Reese said: "Amgen is pleased to present the results of OSLER-1, the longest study of a PCSK9 inhibitor to date, which clearly demonstrate the durable, long-term efficacy and safety of Repatha in reducing LDL-C levels," External link

prnewswire Monday, November 12, 2018 11:02:00 PM CET

David Lane commented: “During this anniversary, Gore is celebrating much more than 15 years since the first implant of GORE SEAMGUARD Reinforcement,” External link

4-traders Monday, November 12, 2018 3:54:00 PM CET

Jaime Ponce recalled: “I first heard about GORE SEAMGUARD Reinforcement just after I started performing sleeve gastrectomies in 2007, when one of my colleagues, Dr. Ninh Nguyen, past-president of the ASMBS, presented data on the decreased bleeding rate from stapling when using GORE SEAMGUARD Reinforcement,” External link

4-traders Monday, November 12, 2018 3:54:00 PM CET

Jaime Ponce concluded: “That GORE SEAMGUARD Reinforcement has remained unchanged for 15 years - a considerable achievement in today’s everchanging medical devices market is a testament to the product’s safety and efficacy,” External link

4-traders Monday, November 12, 2018 3:54:00 PM CET

William O Neill said: "This safety and feasibility study gives us hope that we can help STEMI heart attack patients in the future by unloading the heart muscle with delayed revascularization. The planned pivotal randomized controlled trial will further examine whether unloading with Impella CP for 30 minutes prior to reperfusion will potentially slow down or avoid the development of heart failure," External link

finanznachrichten-en Sunday, November 11, 2018 4:42:00 PM CET

Michael R Minogue said: "We would like to thank the FDA, our dedicated employees, the patients who consented and all the investigators for their efforts to successfully complete this milestone. We look forward to the pivotal study and expanding the clinical science for the field of heart recovery," External link

finanznachrichten-en Sunday, November 11, 2018 4:42:00 PM CET

Lina Begdache says: “These findings suggest that college education on dietary supplements, during a stage when young adults establish lifelong habits, may potentially reduce risk of abuse,” External link

nutritioninsight Saturday, November 10, 2018 4:17:00 AM CET

Steven George says: “The public knows how expensive it is to develop a drug and knows about the lengthy clinical trials,” “The pharmaceutical industry is looking for faster, better ways of predicting how a new substance will work. What’s frustrating for companies is they’ll think they have a promising drug because it worked in flat, petri-dish models, but then when they do an expensive human trial, it fails. Our system potentially changes that, because we’re replicating a variety of human cells in three dimensions that have their own blood supplies” External link

news-uci Friday, November 9, 2018 6:10:00 AM CET

Steven George says: “The main focus of our first-ever industry open house is to stimulate collaboration between the center and the private sector,” “Given the tight federal and state budgets, this has become a much higher priority” External link

news-uci Friday, November 9, 2018 6:10:00 AM CET

Wendy Liu said: “Our strategy harnesses the body’s potential to control inflammation and promote healing, which will hopefully prevent device failure and, ultimately, help cure life-threatening diseases,” External link

news-uci Thursday, November 8, 2018 12:42:00 PM CET

John Laird said: "With the data presented today at VIVA, we continue to see sustained clinical benefit of IN.PACT Admiral with three quarters of DCB patients in the study not requiring a reintervention through five years," "This is truly remarkable considering the complexity and progressive nature of PAD. For these patients, it means we are providing them with a long-term, durable solution that reduces the need for frequent reinterventions, leading to a potential improvement in their quality of life" External link

agrinews Tuesday, November 6, 2018 7:58:00 PM CET

Prof Dr sagt: "Etwa vier Prozent der Menschen über 75 Jahre leiden an einer Aortenklappen-Stenose. Die Zahl der Betroffenen steigt, weil die Menschen älter werden" External link

pressetext Thursday, June 7, 2018 10:12:00 AM CEST

Christian Hengstenberg sagt: "Etwa vier Prozent der Menschen über 75 Jahre leiden an einer Aortenklappen-Stenose. Die Zahl der Betroffenen steigt, weil die Menschen älter werden" External link

pressetext Thursday, June 7, 2018 10:12:00 AM CEST

Prof Dr sagt: "Dieser Ersatz ist deutlich einfacher als bei der Mitralklappe" External link

pressetext Thursday, June 7, 2018 10:12:00 AM CEST

Christian Hengstenberg sagt: "Dieser Ersatz ist deutlich einfacher als bei der Mitralklappe" External link

pressetext Thursday, June 7, 2018 10:12:00 AM CEST

Prof Dr sagt: "Derzeit liegt die Sterblichkeit der Patienten innerhalb des ersten Jahres nach TAVI-Eingriff bei drei bis vier Prozent. Das ist eine sehr positive Entwicklung, vor einigen Jahren waren es noch etwa zehn Prozent" External link

pressetext Thursday, June 7, 2018 10:12:00 AM CEST

Christian Hengstenberg sagt: "Derzeit liegt die Sterblichkeit der Patienten innerhalb des ersten Jahres nach TAVI-Eingriff bei drei bis vier Prozent. Das ist eine sehr positive Entwicklung, vor einigen Jahren waren es noch etwa zehn Prozent" External link

pressetext Thursday, June 7, 2018 10:12:00 AM CEST

Christian Hengstenberg : "Aufgrund der bereits vorliegenden Daten ist anzunehmen, dass die TAVI bald eine Therapieoption für die meisten Patienten mit einer Aortenklappen-Stenose sein wird" External link

pressetext Thursday, June 7, 2018 10:12:00 AM CEST

Christian Hengstenberg : "Am AKH Wien werden solche Eingriffe auch in einem neuen Hybrid-Operationssaal durchgeführt, der sowohl interventionelle Eingriffe als auch das sofortige Wechseln zur Chirurgie ermöglicht. Gleichzeitig stehen alle Möglichkeiten der Herz-Bildgebung zur Verfügung" External link

pressetext Thursday, June 7, 2018 10:12:00 AM CEST

Most associated names

Daily number of articles in this category

Trend data not available for this selection.